Similarly, exposure to TK-216, the clinical derivative of YK-4-279, reduced the interaction of ETS factors SPIB and SPI1 with these RNA helicases in B-cell lymphomas (34). This evidence concerns the gene SPIB and B-cell non-Hodgkin lymphoma.